Prof. Dr. BELGİN SÜSLEYİCİ

Yayın Ağı

Makaleler 54

1. The 10th Santorini conference: Systems medicine, personalised health and therapy. “The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind”, Santorini, Greece, 23–26 May 2022

Visvikis-Siest S., Stathopoulou M. G., Sunder-Plassmann R., Alizadeh B. Z., Barouki R., Chatzaki E., et al.

Frontiers in Genetics , cilt.14, 2023 (SCI-Expanded)

2. Investigation of DPYD, MTHFR and TYMS polymorphisms on 5-fluorouracil related toxicities in colorectal cancer

Cevik M., Namal E., Sener N. D., Koksal U. I., Cagatay P., Deliorman G., et al.

PERSONALIZED MEDICINE , cilt.19, sa.5, ss.435-444, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal Cancer in Turkish Subjects

Cevik M., Namal E., Dinc-Sener N., Iner-Koksal U., Ciftci C., Susleyici B.

GENETIC TESTING AND MOLECULAR BIOMARKERS , cilt.26, sa.5, ss.298-306, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

4. Association of PD-1 and PDL-1 gene polymorphisms with colorectal cancer risk and prognosis

Cevik M., Namal E., Iner-Koksal U., Dinc-Sener N., KARAALP A., Ciftci C., et al.

MOLECULAR BIOLOGY REPORTS , cilt.49, sa.3, ss.1827-1836, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

5. The effects of glipizide on DNA damage and nuclear transport in differentiated 3T3-L1 adipocytes

Cevik M., Caker S., Deliorman G., Cagatay P., KOLDEMİR GÜNDÜZ M., SÜSLEYİCİ B.

MOLECULAR BIOLOGY REPORTS , cilt.49, ss.1151-1159, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

6. INVESTIGATION THE EFFECTS OF TREATMENT PLANTS ON HEAVY METAL LEVELS AND MUTAGENICITY OF WASTEWATERS

Dartan G., Cevik M., Aksu M. B., Can Z. S., Keskins Y., Yurdun T., et al.

FRESENIUS ENVIRONMENTAL BULLETIN , cilt.31, sa.8B, ss.8952-8957, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

7. The effects of SNAI1 rs6125849 gene polymorphism on metastasis and survival in colorectal cancer: Preliminary results from Turkish subjects

Cevik M., Namal E., Sener N. D., Koksal U. I., Deliorman G., Ciftci C., et al.

GENE REPORTS , cilt.24, 2021 (ESCI) Sürdürülebilir Kalkınma

8. Prevalence of CYP2C19 Polymorphisms in Clopidogrel Treated Turkish Patients: Preliminary Results, 2017

SÜSLEYİCİ B., Ciftci C., Yurdakul S., Cevik M., Akdeniz C. S., Canbolat I. P., et al.

Current Pharmacogenomics and Personalized Medicine , cilt.18, sa.2, ss.116-122, 2021 (Scopus)

9. The effect of visfatin rs2110385 gene polymorphism over oral antidiabetic drug response

SÜSLEYİCİ DUMAN B., KOLDEMİR GÜNDÜZ M., KAYHAN F. E., ÇAĞATAY P., TAŞKIN M.

Annals of Medical Research , cilt.28, sa.12, ss.2134, 2021 (Hakemli Dergi)

10. DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel

Bayar E., Cevik M., Caker S., Cagatay P., SÜSLEYİCİ B.

CURRENT DRUG SAFETY , cilt.16, sa.3, ss.252-258, 2021 (ESCI)

11. Alterations in niban gene expression as a response to stress conditions in 3T3-L1 adipocytes

Cevik M., KOLDEMİR GÜNDÜZ M., Deliorman G., SÜSLEYİCİ B.

MOLECULAR BIOLOGY REPORTS , cilt.47, sa.12, ss.9399-9408, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

12. The effects of CYP2C9 and VKORC1 gene polymorphisms on warfarin maintenance dose in Turkish cardiac patients

AKDENİZ C. S., ÇEVİK M., CANBOLAT İ. P., YURDAKUL S., ÇAĞATAY P., ÇİFTÇİ Ç., et al.

FUTURE CARDIOLOGY , cilt.16, ss.645-654, 2020 (ESCI)

13. Warfarin pharmacogenetics in patients with heart valve replacement

Bezci K., Cevik M., Akdeniz C. S., Canbolat I. P., Yurdakul S., SÜNBÜL M., et al.

GENE REPORTS , cilt.20, 2020 (ESCI)

14. Evaluation of Cytotoxicity and Mutagenicity of Wastewater from Istanbul: Data from Hospitals and Advanced Wastewater Treatment Plant

Cevik M., DARTAN G., Ulker M., Bezci K., Deliorman G., Cagatay P., et al.

BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY , cilt.104, sa.6, ss.852-857, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

15. The effects of oral antidiabetics on adipogenesis related gene expressions in 3T3-L1, AML12 cell lines and their co-cultures

KOLDEMİR GÜNDÜZ M., Çevik M., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

Eurasian J. Bio. Chem. Sci , cilt.2, sa.1, ss.29-37, 2019 (Hakemli Dergi)

16. Relationship of Bradykinin B-2 Receptor Gene C-58T Variation with Total-Cholesterol and Glucose in Essential Hypertension

SÜSLEYİCİ B., Gunduz M. K., Zengin S. U., Cagatay P., Bozkus H. M., Bakir N., et al.

BEZMIALEM SCIENCE , cilt.5, sa.1, ss.7-15, 2017 (ESCI) Sürdürülebilir Kalkınma

17. Esansiyel Hipertansiyonda Bradikinin B Reseptör Geni C-58T Polimorfizminin Total-Kolesterol ve Kan Şekeri Üzerine Etkileri

SÜSLEYİCİ DUMAN B., KOLDEMİR GÜNDÜZ M., ZENGİN S. Ü., ÇAĞATAY P., BOZKUŞ H. M., BAKIR N., et al.

Bezmiâlem Science , cilt.5, sa.1, ss.7-15, 2017 (Hakemli Dergi)

18. Obezitede Ran Geni Anlatımının Adipogenez ile İlişkisinin Araştırılması

DEMİR S. B., KOLDEMİR GÜNDÜZ M., ÇEVİK M., ÇİFTÇİ Ç., SÜSLEYİCİ DUMAN B.

İSTANBUL BİLİM ÜNİVERSİTESİ FLORENCE NIGHTINGALE TIP DERGİSİ , cilt.2, sa.3, ss.201-207, 2016 (Hakemli Dergi)

19. Association of Sweet Taste Sensitivity andCaries Experience with BMI and HedonicResponses

HAZNEDAROĞLU E., SÜSLEYİCİ DUMAN B., KOLDEMİR GÜNDÜZ M., ÇAĞATAY P., BAKIR N., BOZKUŞ H. M., et al.

Gavin Journal of Dental Sciences , sa.2016, ss.8-14, 2016 (Hakemli Dergi)

20. KişininGenetik Yapısına Özel Bireysel İlaç Tedavileri Farmakogenetik

SÜSLEYİCİ DUMAN B.

Yeni Türkiye Dergisi Bilim ve Teknoloji Özel Sayısı III , 2016 (Hakemli Dergi)

21. Association of Sweet Taste Receptor Gene Polymorphisms with Dental Caries Experience in School Children

HAZNEDAROĞLU E., Koldemir-Gunduz M., Bakir-Coskun N., Bozkus H. M., Cagatay P., Susleyici-Duman B., et al.

CARIES RESEARCH , cilt.49, sa.3, ss.275-281, 2015 (SCI-Expanded)

22. The Effects of Peroxiredoxin 6 Gene rs41055489 Variation on Oxidative Stress Mechanisms in Human Model Organism

Atasayar Ünver Z., KOLDEMİR GÜNDÜZ M., KAYHAN F. E., KAYMAK G., ZENGİN S. Ü., ÇAĞATAY P., et al.

BEZMIALEM SCIENCE , sa.3, ss.37-42, 2015 (Hakemli Dergi)

23. Histopothological Effects of Fluoxetine on Zebra Fish Danino Rerio Gills

YÖN ERTUĞ N. D., AKBULUT C., ALSARAN M., ÖZTÜRK B., KAYHAN F. E., KAYMAK G., et al.

Elixir Applied Zoology , cilt.89, ss.36709-36711, 2015 (Hakemli Dergi)

24. The Effects of Peroxiredoxin 6 Gene rs41055498 Variation on Oxidative Stress Mechanisms in Human Model Organism

ATASAYAR ÜNVER Z., KOLDEMİR GÜNDÜZ M., KAYHAN F. E., KAYMAK G., ZENGİN S. Ü., ÇAĞATAY P., et al.

Bezmialem Science , 2015 (Hakemli Dergi)

25. Mangan süperoksit dismütaz Ala16Val gen polimorfizmlerinin koroner arter olaylarında koruyucu rollerinin araştırılması

ATMACA H., KOLDEMİR GÜNDÜZ M., ÇAĞATAY P., ÇEVİK M., SÜSLEYİCİ DUMAN B.

FNG& Bilim Tıp Dergisi , cilt.1, sa.3, ss.134-144, 2015 (Hakemli Dergi)

26. Zebra balıklarında (Danio rerio) ağır metal indüksiyonunun oksidatif stres parametrelerine etkisi.

Kayhan F. E., Atasayar Ünver Z., Koldemir Gündüz M., Süsleyici B., Sesal N. C.

Journal of Fisheries Sciences , cilt.8, sa.3, ss.199-207, 2014 (Hakemli Dergi)

27. The relationship of Bradykinin B₂ receptor gene variation with obesity, hypertension and lipid variables in obese patients

Bakir N., Bozkuş H. M., KOLDEMİR GÜNDÜZ M., Çağatay P., Taşkın M., Süsleyici Duman B.

Acta medica academica , cilt.43, sa.2, ss.144-154, 2014 (Scopus)

28. Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension

Kayhan F. E., Koldemir M., Çağatay P., Çiftçi P., Süsleyici Duman B.

Diabetes and Metabolic Syndrome: Clinical Research and Reviews , cilt.7, sa.1, ss.12-16, 2013 (Scopus)

29. 11 beta-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease

Atalar F., Vural B., Ciftci C., Demirkan A., Akan G., Susleyici-Duman B., et al.

GENETICS AND MOLECULAR RESEARCH , cilt.11, sa.3, ss.3122-3132, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Relationship of RIC-3 gene rs1528133 polymorphism with varying degrees of body weight and eating behavior.

Koldemir M., Kahveci C., Bayer H., Cagatay P., Yildiz S., Bagriacik N., et al.

Diabetes & metabolic syndrome , cilt.6, sa.2, ss.90-95, 2012 (Scopus)

31. Relationship of transcription factor 7 like 2 gene rs7903146 variation with type 2 diabetes and obesity related parameters

Kahveci C., Koldemir M., Cagatay P., Bayer H., Yildiz S., Bagriacik N., et al.

Diabetes and Metabolic Syndrome: Clinical Research and Reviews , cilt.6, sa.1, ss.48-53, 2012 (Scopus) Sürdürülebilir Kalkınma

32. FTO mRNA Expression in Extremely Obese and Type 2 Diabetic Human Omental and Subcutaneous Adipose Tissues

Susleyici-Duman B., Zengin K., KAYHAN F. E., Koldemir M., Dagistanli F. K., Cagatay P., et al.

OBESITY SURGERY , cilt.21, sa.11, ss.1766-1773, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Heat Shock Protein Genes in Fish

KAYHAN F. E., Duman B.

TURKISH JOURNAL OF FISHERIES AND AQUATIC SCIENCES , cilt.10, sa.2, ss.287-293, 2010 (SCI-Expanded)

34. Genetics of obesity: Medical education Obezite Genetiǧi

Süsleyici Duman B., KAYHAN F. E., Sesal C.

Turkiye Klinikleri Journal of Medical Sciences , cilt.29, sa.2, ss.520-525, 2009 (SCI-Expanded)

35. Tip 2 diabet ve obezitede gen ontoloji ve yolak analizleri ile ekspresyon profilinin irdelenmesi

SÜSLEYİCİ DUMAN B., KAYHAN F. E., SESAL N. C.

Diabet Bilimi , 2009 (Hakemli Dergi) Sürdürülebilir Kalkınma

36. Common Variants in the ATP-binding Cassette Transporter 1 Gene with Decreased HDL-Cholesterol Levels and Coronary Artery Disease

Catakoglu A. B., Duman B., Kurtoglu H., ERSÖZ M., Sener M., Celebi H., et al.

ARCHIVES OF MEDICAL RESEARCH , cilt.39, sa.8, ss.735-742, 2008 (SCI-Expanded)

37. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome

Vural B., Atalar F., Ciftci C., Demirkan A., Susleyici-Duman B., Gunay D., et al.

CARDIOVASCULAR PATHOLOGY , cilt.17, sa.6, ss.392-398, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

38. Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease

Ciftci C., Melil S., Cebi Y., Ersoz M., Cagatay P., Kilicgedik M., et al.

LIPIDS IN HEALTH AND DISEASE , cilt.7, 2008 (SCI-Expanded)

39. Association of resistin gene 3′-untranslated region EX4-44G→A polymorphism with obesity- and insulin-related phenotypes in Turkish type 2 diabetes patients

Duman B., Cagatay P., Hatemi H., ÖZTÜRK SEZGİN M.

Review of Diabetic Studies , cilt.4, sa.1, ss.49-55, 2007 (Scopus) Sürdürülebilir Kalkınma

40. Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: Meta-analysis

Cagatay P., Susleyici-Duman B., Ciftci C.

DISEASE MARKERS , cilt.23, sa.3, ss.161-166, 2007 (SCI-Expanded)

41. Apolipoprotein B gene variants are involved in the determination of blood glucose and lipid levels in patients with non-insulin dependent diabetes mellitus

Duman B., ÖZTÜRK SEZGİN M., Yilmazer S., Çaǧatay P., Hatemi H.

Cell Biochemistry and Function , cilt.24, sa.3, ss.261-267, 2006 (SCI-Expanded)

42. DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with non-insulin dependent diabetes mellitus

Duman B., Ozturk M., Yilmazer S., Cagatay P., Hatemi H.

CELL BIOCHEMISTRY AND FUNCTION , cilt.23, sa.6, ss.399-404, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

43. Protective effects of a calcium channel blocker on apoptosis in thymus of neonatal STZ-diabetic rats

Daǧistanli F. K., Duman B., ÖZTÜRK SEZGİN M.

Acta Histochemica , cilt.107, sa.3, ss.207-214, 2005 (SCI-Expanded)

44. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease

Duman B., Turkoglu C., Akpinar B., Guden M., Vertii A., Cagatay P., et al.

ANNALS OF HUMAN BIOLOGY , cilt.32, sa.5, ss.620-629, 2005 (SCI-Expanded)

45. The effects of phase II cardiac rehabilitation programme on patients undergone coronary bypass surgery Koroner baypas geçiren olgularda faz II kardiyak rehabilitasyon programinin etkileri

Çiftçi Ç., Duman B., Çaǧatay P., Demiroǧlu C., Aytekin V.

Anadolu Kardiyoloji Dergisi , cilt.5, sa.2, ss.116-121, 2005 (Scopus)

46. Polymorphisms at the ligand binding site of the vitamin D receptor gene and osteomalacia

AK S., Kahraman H., DURSUN E., Duman B., Erensoy N., Alagöl F., et al.

Disease Markers , cilt.21, sa.4, ss.191-197, 2005 (SCI-Expanded)

47. Koroner baypas geçiren olgularda faz II kardiyak rehabilitasyon programının etkileri

ÇİFTÇİ Ç., SÜSLEYİCİ DUMAN B., ÇAĞATAY P., DEMİROĞLU C., AYTEKİN V.

Anadolu Kardiyoloji Dergisi , cilt.5, ss.116-121, 2005 (Hakemli Dergi)

48. Programmed cell death in heart failure: Review Programli hücre ölümünün kalp yetersizliǧ indeki yeri

Süsleyici Duman B., Türkoǧlu Ç., ÖZTÜRK SEZGİN M.

Turkiye Klinikleri Journal of Medical Sciences , cilt.25, sa.1, ss.85-92, 2005 (Scopus)

49. Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease

Duman B., Türkoǧlu Ç., Akpinar B., Güden M., Vertii A., Dak E., et al.

Archives of Pathology and Laboratory Medicine , cilt.128, sa.8, ss.869-874, 2004 (SCI-Expanded)

50. Lack of association between vitamin D receptor gene polymorphism (BsmI) and osteomalacia

Kahraman H., Duman B., Alagöl F., Tanakol R., Yilmazer S.

Journal of Bone and Mineral Metabolism , cilt.22, sa.1, ss.39-43, 2004 (SCI-Expanded)

51. Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women

Duman B., Tanakol R., Erensoy N., Ozturk M., Yilmazer S.

MEDICAL PRINCIPLES AND PRACTICE , cilt.13, sa.5, ss.260-266, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

52. Thiols, malonaldehyde status in the Turkish and total antioxidant patients with type 2 diabetes mellitus

Duman B., Ozturk M., Yilmazer S., Hatemi H.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , cilt.201, sa.3, ss.147-155, 2003 (SCI-Expanded)

53. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: Evidence supporting obesity as the central feature

Turkoglu C., Duman B., Gunay D., Cagatay P., Ozcan R., Buyukdevrim A.

OBESITY SURGERY , cilt.13, sa.5, ss.699-705, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

54. The interrelationship between insulin secretion and action in Type 2 diabetes mellitus with different degrees of obesity: Evidence supporting central obesity

Susleyici Duman B., Turkoglu C., Gunay D., Cagatay P., Demiroglu C., Sevin Buyukdevrim A.

Diabetes, Nutrition and Metabolism - Clinical and Experimental , cilt.16, sa.4, ss.243-250, 2003 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 49

1. Noise Suppression on In-line Holograms with a Hybrid Method Using U-Net and Transformer Architectures U-Net ve Transformer Mimarilerini Kullanan Hibrit Bir Y ntem ile Eksen- st Hologramlarda G r lt Bastirimi

SÜSLEYİCİ B., Gokgoz F., Ozturk A., ESMER G. B.

33rd IEEE Conference on Signal Processing and Communications Applications, SIU 2025, İstanbul, Türkiye, 25 - 28 Haziran 2025, (Tam Metin Bildiri)

2. Relationship of Vitamin D Receptor Gene Polymorphisms with Adverse Drug Responses In Patients With Colorectal Cancer

Tosun M., ÇEVİK M., SÖNMEZ Ö., ER Ö., DEMİR O. G., OYAN ULUÇ B., et al.

9th International Molecular Biology and Biotechnology Congress, 6 - 10 Aralık 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Tramadol: From CYP2D6 Pharmacogenetic Testing To Clinical Dat

ÇEVİK M., KARAALP A., GÜNDÜZ O. H., YAZICI G., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

5th ESPT Congress Precısıon Medıcıne and Personalised Health, Sevilla, İspanya, 16 - 18 Ekim 2019, (Özet Bildiri)

4. The Effıcıency of PPI Use in Turkısh Patıents: CYP2C19 Pharmacogenetıc Testıng

SÜSLEYİCİ DUMAN B., ÇEVİK M., KARAALP A., YURDAKUL S., CANBOLAT İ. P., GÜNDÜZ O. H., et al.

5th ESPT Congress Precısıon Medıcıne and Personalised Health, 16 - 18 Ekim 2019, (Özet Bildiri)

5. Effects of oral antidiabetics on oxidative stress parameters in liver metabolism

KOLDEMİR GÜNDÜZ M., KAYMAK G., ÇEVİK M., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

2nd International Eurasian Conference on Biological and Chemical Science, 28 - 29 Haziran 2019, (Tam Metin Bildiri)

6. The effects of oral antidiabetics on adipogenesis related gene expressions in 3T3-L1, AML12 cell lines and their co-cultures

KOLDEMİR GÜNDÜZ M., Çevik M., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

2nd International Eurasian Conference on Biological and Chemical Sciences, 28 - 29 Haziran 2019, (Özet Bildiri)

7. Implementation of Pharmacogenetics in Turkish Clinical Practice:Challenges and Opportunities

SÜSLEYİCİ DUMAN B.

International Congress on Biological and Medical Sciences 2018, 31 Ekim - 03 Kasım 2018, (Özet Bildiri)

8. Pharmacogenetics Of Clopidogrel In Coronary Artery Disease Patients: Results From Turkish Clinical Practice

SÜSLEYİCİ DUMAN B., ÇİFTÇİ Ç., KARAALP A., ÇEVİK M., YURDAKUL S., CANBOLAT İ. P., et al.

The 9th Santorını Conference Systems Medıcıne and Personalısed Health Therapy « The Odyssey From Hope To Practice », Santorini, Yunanistan, 30 Eylül - 03 Ekim 2018, (Özet Bildiri)

9. Implementatıon Of Pharmacogenetics In Turkish Clinical Practice: The Example Of Dihydropyrimidine Dehydrogenase

SÜSLEYİCİ DUMAN B.

The 9 th Santorini Conference “Systems medicine and Personalised Health and Therapy”: The Odyssey from Hope to Practice, Santorini, Yunanistan, 30 Eylül - 03 Ekim 2018, (Özet Bildiri)

10. Pharmacogenetics: Implementing Personalized Medicine in Turkish Clinical Practice

SÜSLEYİCİ DUMAN B.

IV. Intenational Congress on Applied Biological Sciences, 3 - 05 Mayıs 2018, (Özet Bildiri)

11. Rational Drug Applications to Individuals Specific Genetic Structure:Pharmacogenetic

SÜSLEYİCİ DUMAN B.

1st International Health Sciences Congress, 23 - 25 Kasım 2017, (Özet Bildiri)

12. The Effects of Glipizide and Acarbose on Obesity and Glucose Metabolism in 3T3-L1, AML12 cell lines and their co-cultures

KOLDEMİR GÜNDÜZ M., ÇEVİK M., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

İVEK Uluslararası İlaç ve Eczacılık Kongresi, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Investigation Of The Effects Of Clopidogrel In AML12 Hepatocyte Cell Line Over Mitochondrial Activity. Mitochondrial Activity

KARABAY M. C., KUTLU D., ÇARPAR E., ÇEVİK M., SÜSLEYİCİ DUMAN B.

5 th National amp 3 rd Mediterranean Congres for the Surgery of Obesity and Metabolic Dersorders, Antalya, Türkiye, 12 - 15 Ekim 2017, (Özet Bildiri)

14. The Effects of Clopidogrel on CD68 Gene Expression in Adipocyte, Hepatocyte Cell Lines and Co-cultures

BAYAR E., ÇEVİK M., ÇAKER S., SÜSLEYİCİ DUMAN B.

5th National 3rd Mediterranean Congress for the Surgery of Obesity and Metabolic Disorders, Antalya, Türkiye, 12 - 15 Ekim 2017, (Özet Bildiri)

15. Role of genetics in the selection of surgical methods and its use as a primary treatment

SÜSLEYİCİ DUMAN B.

Congress for the surgery of obesity and metabolic disorders, 12 - 15 Ekim 2017, (Özet Bildiri)

16. Investigation of the Effects of Clopidogrel in AML Hepatocyte Cell Line Over Membrane Integrity

KUTLU D., KARABAY M. C., ÇARPAR E., ÇEVİK M., SÜSLEYİCİ DUMAN B.

5 th National amp 3 rd Mediterranean Congres for the Surgery of Obesity and Metabolic Dersorders, Antalya, Türkiye, 12 - 15 Ekim 2017, (Özet Bildiri)

17. Investigation Of The Effects Of Clopidogrel In AML12 Hepatocyte Cell Line Over Lysosomal Activity

ÇARPAR E., KARABAY M. C., KUTLU D., ÇEVİK M., SÜSLEYİCİ DUMAN B.

5 th National amp 3 rd Mediterranean Congres for the Surgery of Obesity and Metabolic Dersorders, Antalya, Türkiye, 12 - 15 Ekim 2017, (Özet Bildiri)

18. Genetic Polymorphisms of CYP3A4 1B In Patients With Coronary Artery Disease Using Statin

GEZER E., ÇEVİK M., BEZCİ K., ÜLKER M., ÇATMAZ Ö., YURDAKUL S., et al.

4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, KATANYA, İtalya, 4 - 07 Ekim 2017, (Özet Bildiri)

19. Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel

ÇATMAZ Ö., ÇEVİK M., GEZER E., BEZCİ K., ÜLKER M., YURDAKUL S., et al.

4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation, Catalunya, İspanya, 4 - 07 Ekim 2017, (Özet Bildiri)

20. Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin

BEZCİ K., ÇEVİK M., GEZER E., ÜLKER M., ÇATMAZ Ö., YURDAKUL S., et al.

4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, Catalunya, İspanya, 4 - 07 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

21. The Effects of Clopidogrel on DNA damage in Adipocyte and Hepatocyte Cell Lines

BAYAR E., ÇEVİK M., ÇAKER S., SÜSLEYİCİ DUMAN B.

4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, Catalunya, İspanya, 4 - 07 Ekim 2017, (Özet Bildiri)

22. National drug applications to ındividiual specific genetic structure:Pharmacogenetics

SÜSLEYİCİ DUMAN B.

Innovation in medicine summit 3 in drug and biotechnology, 11 - 13 Mayıs 2017, (Özet Bildiri)

23. Glipizidin Adipositlerde Glikoz Hemostazı ve Programlı Hücre Ölümüne Etkilerinin Moleküler Seviyede Araştırılması

ÇAKER S., ÇEVİK M., KOLDEMİR GÜNDÜZ M., BAYAR E., SÜSLEYİCİ DUMAN B.

İVEK Uluslararası İlaç ve Eczacılık Kongresi, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

24. Effects of metformin on oxidative stress parameters in 3T3-L1 adipocytes by iCELLigence system

GÜNDÜZ KOLDEMİR M., ÇEVİK M., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

İVEK Uluslararası İlaç ve Eczacılık Kongresi, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

25. The effect of glipizide and acarbose on obesity and glucose metabolism in 3T3-L1, AML12 cell lines and their co-cultures

KOLDEMİR GÜNDÜZ M., Çevik M., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

IVEK 3nd International Convention of Pharmaceuticals and Pharmacies, 26 - 29 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

26. Effect of metformin on oxidative stress parameters in 3T3-L1 adipocytes by iCELLigence system

KOLDEMİR GÜNDÜZ M., Çevik M., ÇAĞATAY P., SÜSLEYİCİ DUMAN B.

IVEK 3nd International Convention of Pharmaceuticals and Pharmacies, 26 - 29 Nisan 2017, (Özet Bildiri)

27. Farmakogenetiğin ve nütrigenetiğin obezite cerrahisindeki rolü ve gelecek/obezite cerrahisinde güncel farmakogenetik ve nütrigenetik yaklaşımlar

SÜSLEYİCİ DUMAN B.

Cerrahpaşa cerrahi toplantıları-Türk obezite cerrahisi derneği 2.kış okulu, Türkiye, 27 - 28 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

28. BARX1 is down regulated in children with non syndromicsupernumerary teeth

MENTEŞ A. R., PEKEL B., ÇEVİK M., KOLDEMİR GÜNDÜZ M., SÜSLEYİCİ DUMAN B.

the Ninth International Symposium on Dental Enamel: “Enamel 9”., 30 Ekim - 03 Kasım 2016, (Tam Metin Bildiri)

29. Pharmacogenomics and Pharmacomicrobiomics in Precision Medicine

SÜSLEYİCİ DUMAN B.

24th Meeting of Balkan Clinical Laboratory Federation 4th Albanian National Conference of Laboratory Medicine, Arnavutluk, 5 - 07 Ekim 2016

30. Personalized Medicine Pharmacotherapy Pharmacogenetics

SÜSLEYİCİ DUMAN B.

International Conference on Science and Technology, Türkiye, 3 - 06 Ekim 2016

31. Yeni Teknolojiler Işığında Bireye Özgü İlaç Tedaviler Farmokogenetik Yaklaşım

SÜSLEYİCİ DUMAN B.

GLAB Açılış Toplantısı, Türkiye, 26 Eylül 2016

32. Implementation of Pharmacogenomics in Turkey

SÜSLEYİCİ DUMAN B.

3rd ESPT Summer School, 20 - 25 Ağustos 2016

33. Investigatio of Gain Loss Deletion of Genomic Copy Number Variant in Children with Non syndromic Supernumerary Teeth

MENTEŞ A. R., PEKER B., ÇEVİK M., KOLDEMİR GÜNDÜZ M., SÜSLEYİCİ DUMAN B.

Tooth Morphogenesis & Differentiation 2016 - Road to Finland, 13 - 18 Haziran 2016

34. Investigation of Gain Loss Deletion of Genomic Copy Number Variants in Children with Non syndromic Supernumerary Teeth

MENTEŞ A. R., Pekel B., Çevik M., KOLDEMİR GÜNDÜZ M., SÜSLEYİCİ DUMAN B.

TMD 2016, 13 - 18 Haziran 2016, (Özet Bildiri)

35. Obezite İlişkili Hastalıkların Bireye Özgü Tedavisinde Yeni Boyut Farmakogenetik

SÜSLEYİCİ DUMAN B.

ULUSAL MOLEKÜLER TIP SEMPOZYUMU, Türkiye, 1 - 03 Haziran 2016 Sürdürülebilir Kalkınma

36. Innovations in Pharmacogenomics and Individualized Treatments

SÜSLEYİCİ DUMAN B.

Tıpta İnovasyon Buluşmaları-2, Gaziantep, Türkiye, 5 - 07 Mayıs 2016

37. The Effects of Oral Antidiabetic Drug Metformin on Liver Metabolism by Real Time Cell Monitoring System

KOLDEMİR GÜNDÜZ M., ZENGİN S. Ü., TAŞKIN M., SÜSLEYİCİ DUMAN B.

20th WORLD CONGRESS OF THE IFSO, Avusturya, 1 - 02 Mayıs 2016, (Tam Metin Bildiri)

38. Öngörüsel Tıp Uygulamasında Farmakogenetik

SÜSLEYİCİ DUMAN B.

XII İÜGEN Uluslarası Katılımlı Moleküler Biyoloji ve Genetik Kış Okulu, 4 - 06 Mart 2016

39. Effects of Fluoxetine HCl on AML 12 Hepatocytes Proliferation by iCELLigence System

KOLDEMİR GÜNDÜZ M., ÇEVİK M., KAYMAK G., TARTAR Ş., ESMER H. E., KAYHAN F. E., et al.

2nd IVEK International Convention of Pharmaceuticals and Pharmacies, Istanbul, Türkiye, 27 - 29 Kasım 2015

40. The role of Apolipoprotein B polymorphisms in essential hypertension

ÇEVİK M., KOLDEMİR GÜNDÜZ M., ÇAĞATAY P., ÇİFTÇİ Ç., SÜSLEYİCİ DUMAN B.

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Türkiye, 27 - 28 Kasım 2015

41. Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model

BEYHAN ÖZDAŞ Ş., AKIN D., DEMİRCAN G., YAPIŞLAR H., KETENCİ S., KOLDEMİR GÜNDÜZ M., et al.

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Türkiye, 27 - 28 Kasım 2015, (Özet Bildiri)

42. The effects of stem cell therapy on CD68 FTO and RAN expression in fructose induced metabolic syndrome rat model for personalized therapy

KOLDEMİR GÜNDÜZ M., ÇEVİK M., AKIN D., BEYHAN ÖZDAŞ Ş., DEMİRCAN G., ÇİFTÇİ Ç., et al.

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Türkiye, 27 - 28 Kasım 2015, (Özet Bildiri)

43. The effects of glipizide on adipogenesis related gene expressions by using impedance cell based label free technology in mature adipocytes

KOLDEMİR GÜNDÜZ M., SÜSLEYİCİ DUMAN B.

3rd ESPT Conference. Integration of Pharmacogenomics in Clinical Desicion Support, Macaristan, 7 - 09 Ekim 2015, (Özet Bildiri)

44. The effects of cytotoxic agents over NIBAN gene expression and 3T3 L1 adipocyte proliferation

ÇEVİK M., KOLDEMİR GÜNDÜZ M., SÜSLEYİCİ DUMAN B.

3rd ESPT Conference. Integration of Pharmacogenomics in Clinical Desicion Support, Macaristan, 7 - 09 Ekim 2015

45. The effects of oral antidiabetic drug metformin on liver metabolism by real time cell monitoring system

KOLDEMİR GÜNDÜZ M., ZENGİN S. Ü., TAŞKIN M., SÜSLEYİCİ DUMAN B.

IFSO 20th World Congress. 20th World Congress of International Federation for the Surgery of Obesity&Metabolic Disorders, Avusturya, 26 - 29 Ağustos 2015

46. The Effects of Oxidative Stress Agents on FTO and CD68 gene expressions and free radical production in 3T3 L1 Adipocytes

KOLDEMİR GÜNDÜZ M., ÇEVİK M., ÇAĞATAY P., AYDIN A., SÜSLEYİCİ DUMAN B.

International Symposium on Advancesin Predictive and Personalized Medicine “Bridging Nations in Istanbul: Personalized and Predictive Medicine in Turkey, Türkiye, 2 - 03 Nisan 2015, (Özet Bildiri)

47. The effects of oral antidiabetic drug glipizide on liver metabolism by real time cell monitoring system

KOLDEMİR GÜNDÜZ M., SÜSLEYİCİ DUMAN B.

International Symposium on Advancesin Predictive and Personalized Medicine “Bridging Nations in Istanbul: Personalized and Predictive Medicine in Turkey, Türkiye, 2 - 03 Nisan 2015

48. Investigesion of Association with TAS1R3 Gene rs307355 Polymorphism and Sweet Taste Perception in School Children

Bakır N., HAZNEDAROĞLU E., KOLDEMİR GÜNDÜZ M., ÇAĞATAY P., MENTEŞ A. R., SÜSLEYİCİ DUMAN B.

2st International Congress of the Molecular Biology Association of Turkey 2013, 22 - 23 Kasım 2013, (Özet Bildiri)

49. Association of endothelial nitric oxide synthase promoter region T 786C gene polymorphism with acute coronary syndrome and coronary heart disease

ÇİFTÇİ Ç., MELİL S., ÇEBİ Y., ERSÖZ M., ÇAĞATAY P., KILIÇGEDİK M., et al.

Lipids in Health and Disease, 15 Eylül 2028 - 18 Eylül 2027, cilt.7, (Tam Metin Bildiri)

Kitaplar 3

Metrikler

Yayın

107

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

253

H-İndeks (WoS)

Atıf (Scopus)

488

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Toplam Atıf Sayısı

264

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Toplam Atıf Sayısı

Proje

Tez Danışmanlığı

Açık Erişim